ZMYND8 and Miyoshi myopathy: The development of safe and effective inhibitors of IRE1α for MM therapy is urgently needed.[39] We found that ZMYND8 or CEBPE overexpression significantly inhibited IRE1α and XBP1s, which blocked the adaptive stress responses required for MM cell survival.